These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 13745527)

  • 21. The effect of varying doses of methyltestosterone, testosterone propionate and fluoxymesterone on the functions and structure of the liver and testicles in rabbits.
    HEPLER AB
    West J Surg Obstet Gynecol; 1960; 68():276-81. PubMed ID: 13713480
    [No Abstract]   [Full Text] [Related]  

  • 22. [2-hydroxymethylene-17- alpha-methyldihydrotestosterone as an anabolic agent. Clinical results].
    GOMEZ MONT F; HERRERA LASSO L
    Prensa Med Mex; 1960 May; 25():255-62. PubMed ID: 13706806
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical study of I-dehydro-17 alpha-methyltestosterone].
    BRANCACCIO A; D'ALESSANDRO B; DELUCA R; JACONO G
    Minerva Med; 1960 Mar; 51():980-2. PubMed ID: 13803824
    [No Abstract]   [Full Text] [Related]  

  • 24. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties.
    Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P
    Toxicol Lett; 2006 Aug; 165(2):149-55. PubMed ID: 16621347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical evaluation of an anabolic agent administered to underweight patients in a gastrointestinal clinic.
    BAROWSKY H; RECHTSCHAFFEN J; SCHWARTZ SA
    Am J Gastroenterol; 1961 Jan; 35():37-41. PubMed ID: 13687219
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypocholesteremic effect of 17 alpha-methyltestosterone in dogs.
    ABELL LL; MOSBACHEH ; KENDALL FE
    Circ Res; 1962 Jun; 10():846-50. PubMed ID: 13858920
    [No Abstract]   [Full Text] [Related]  

  • 27. Sex-specific effects of chronic anabolic androgenic steroid treatment on GABA(A) receptor expression and function in adolescent mice.
    Penatti CA; Porter DM; Jones BL; Henderson LP
    Neuroscience; 2005; 135(2):533-43. PubMed ID: 16112473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical use of a new derivative of testosterone (dianbol) with anabolic action].
    SCALFI GF; PONTIGGIA P; DI STEF ANO A; ROSSI T
    Minerva Med; 1961 Feb; 52():393-4. PubMed ID: 13747033
    [No Abstract]   [Full Text] [Related]  

  • 29. [Androgenic and anabolic activity of a new enolic derivative of testosterone active by oral route. Clinical research].
    BUTTURINI U
    Folia Endocrinol Mens Incretologia Incretoterapia; 1960 Dec; 13():765-78. PubMed ID: 13689496
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of delta I, 17 alpha methyl testosterone as an adjuvant in the treatment of schizophrenic reactions.
    LAPINSOHN LI
    Dis Nerv Syst; 1961 Aug; 22():443-8. PubMed ID: 13759024
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of methyltestosterone to stimulate growth: relative influence on skeletal maturation and linear growth.
    SOBEL EH; RAYMOND CS; QUINN KV; TALBOT NB
    J Clin Endocrinol Metab; 1956 Feb; 16(2):241-8. PubMed ID: 13286320
    [No Abstract]   [Full Text] [Related]  

  • 32. Partial filling micellar electrokinetic chromatography analysis of androgens and testosterone derivatives using two sequential pseudostationary phases.
    Amundsen LK; Sirén H
    J Chromatogr A; 2006 Oct; 1131(1-2):267-74. PubMed ID: 16949594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the ability of methyltestosterone to counteract catabolism in diverse conditions of stress.
    SELYE H; MISHRA RK
    Arch Int Pharmacodyn Ther; 1958; 117(3-4):444-51. PubMed ID: 13606951
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical and biochemical aspects of the action of anabolic steroids].
    HAAK A; QUERIDO A; KASSENAAR AA
    Ned Tijdschr Geneeskd; 1960 Oct; 104():2052-60. PubMed ID: 13710167
    [No Abstract]   [Full Text] [Related]  

  • 35. [Determination of methyltestosterone in tablets containing other materials also].
    van der MIJLL DEKKER L
    Pharm Weekbl; 1961 Dec; 96():961-5. PubMed ID: 14473667
    [No Abstract]   [Full Text] [Related]  

  • 36. [Jaundice subsequent to treatment with methyltestosterone].
    KADISH U
    Harefuah; 1958 May; 54(10):256-7. PubMed ID: 13548692
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical observations on the use of 19-nortestos-terone propionate; further contribution to the study of anabolic steroids].
    BASSI G
    Endocrinol Sci Cost; 1958; 24(5):392-400. PubMed ID: 13597848
    [No Abstract]   [Full Text] [Related]  

  • 38. Jaundice due to methyltestosterone therapy.
    KAPLAN AA
    Gastroenterology; 1956 Oct; 31(4):384-90. PubMed ID: 13365845
    [No Abstract]   [Full Text] [Related]  

  • 39. [Methyltestosterone therapy in pruritus with jaundice].
    LANGE HF
    Tidsskr Nor Laegeforen; 1957 Oct; 77(20):912-3. PubMed ID: 13519475
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the effect of anabolic hormone on azotemia in kidney failure].
    GERBER W; COTTIER P
    Helv Med Acta; 1961 May; 28():197-215. PubMed ID: 13704561
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.